1. Home
  2. BMM vs EVO Comparison

BMM vs EVO Comparison

Compare BMM & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Moon Metals Inc. Common Shares

BMM

Blue Moon Metals Inc. Common Shares

HOLD

Current Price

$4.00

Market Cap

541.1M

Sector

N/A

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.53

Market Cap

568.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMM
EVO
Founded
2007
1993
Country
Canada
Germany
Employees
68
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.1M
568.6M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
BMM
EVO
Price
$4.00
$1.53
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $4.23
AVG Volume (30 Days)
★ 217.5K
83.4K
Earning Date
11-23-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.47
$1.33
52 Week High
$8.63
$4.19

Technical Indicators

Market Signals
Indicator
BMM
EVO
Relative Strength Index (RSI) 33.02 45.54
Support Level $3.47 $1.50
Resistance Level $6.68 $1.97
Average True Range (ATR) 0.23 0.05
MACD -0.05 0.02
Stochastic Oscillator 13.39 60.73

Price Performance

Historical Comparison
BMM
EVO

About BMM Blue Moon Metals Inc. Common Shares

Blue Moon Metals Inc is a Canadian exploration stage company focused on the exploration and development of mineral resource properties. The company is advancing its Blue Moon polymetallic deposit which contains zinc, gold, silver, and copper. The projects of the company include the Nussir copper-gold-silver property in Norway (the "Nussir Property"), the Blue Moon zinc-copper-gold-silver property in California, USA (the "Blue Moon Property"), the NSG copper-zinc-gold-silver property in Norway (the "NSG Property") the Springer tungsten-molybdenum project in the Nevada, USA (the "Springer Property") and the Apex germanium-gallium-copper project in Utah, USA (the "APEX Property").

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: